financetom
Business
financetom
/
Business
/
First Solar lowers annual sales forecast, posts rise in Q3 profit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
First Solar lowers annual sales forecast, posts rise in Q3 profit
Nov 3, 2024 2:27 PM

(Reuters) - U.S. solar panel maker First Solar ( FSLR ) lowered its sales forecast for the current year on Tuesday, even after reporting a rise in third-quarter profit helped by higher prices following additional tariffs on foreign-made panels.

Shares were down 6.9% at $185.99 in after-market trade.

Residential installations have fallen sharply this year, and utility-scale projects face challenges including long waits to connect to the grid and a shortage of skilled labor.

The company lowered its full-year 2024 sales forecast to between $4.10 billion and $4.25 billion, from its previous expectation of between $4.4 billion to $4.6 billion.

The company reported a sequential decline in quarterly sales, hurt by a decrease in the volume of megawatt (MW) sold.

However, the company reported a 16.6% rise in net profit for the quarter ended Sept. 30, at $313 million, or $2.91 per share, compared with a year earlier.

The Biden administration imposed new tariffs on foreign-made solar modules in May, benefiting U.S. companies like First Solar ( FSLR ) that produce domestically.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Spice maker McCormick beats quarterly results on strong EMEA business
Spice maker McCormick beats quarterly results on strong EMEA business
Jun 27, 2024
(Reuters) - McCormick ( MKC ) beat market expectations for second-quarter profit and sales on Thursday, led by strong demand for its spices and seasonings in Europe, Middle East and Africa. Customers grappling with still-high costs preferred cooking at home to dining out, improving volumes across the company's consumer segment, its biggest unit. Consumer sales in Europe, Middle East and...
Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month
Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month
Jun 27, 2024
June 27 (Reuters) - Verona Pharma's therapy for treating a chronic lung disease will be sold in the U.S. at a wholesale price of $2,950 per month, the U.K.-based company said on a conference call on Thursday. The U.S. health regulator's assent on Wednesday for the therapy, branded as Ohtuvayre, provides a new inhaled non-steroidal treatment for chronic obstructive pulmonary...
Andlauer Healthcare to Launch Normal Course Issuer Bid
Andlauer Healthcare to Launch Normal Course Issuer Bid
Jun 27, 2024
09:00 AM EDT, 06/27/2024 (MT Newswires) -- Andlauer Healthcare Group ( ANDHF ) said Thursday that it secured TSX approval for a normal course issuer bid (NCIB) for up to 10% of its public float over the next 12 months. The company said it can purchase its shares for cancellation beginning on July 2 and until July 1, 2025. Andlauer...
BRIEF-Argonautic Ventures Says Preliminary Non-Binding Proposal To Benson Hill's Board Related To Proposed Acquisition By To-Be-Formed Acquisition Vehicle
BRIEF-Argonautic Ventures Says Preliminary Non-Binding Proposal To Benson Hill's Board Related To Proposed Acquisition By To-Be-Formed Acquisition Vehicle
Jun 27, 2024
June 27 (Reuters) - Benson Hill Inc ( BHIL ): * ARGONAUTIC VENTURES - PRELIMINARY NON-BINDING PROPOSAL TO BENSON HILL'S BOARD RELATED TO PROPOSED ACQUISITION BY TO-BE-FORMED ACQUISITION VEHICLE * ARGONAUTIC VENTURES-PROPOSAL TO BENSON HILL'S BOARD RELATED TO PROPOSED ACQUISITION ALL OF OUTSTANDING SHARES FOR CASH CONSIDERATION OF $0.2236/SHARE Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved